Zonisamide improves cognitive impairment and psychiatric symptoms related with SAPAP3 in mouse models of Alzheimer's disease.

Fangtai Yi; Jianfeng Ma; Ruiyue Zhao; Qiuyu Xie; Sitong Lu; Kailong Zhang; Zuodong Zhong; Huijuan OuYang; Yuan Qin; Mingheng Xu; Qin Xue; Xinlu Wang; Wei Wei; Yinghua Liu

doi:10.1016/j.ejphar.2026.179279

SCHEDA SCIENTIFICA2026Altra ricerca

Zonisamide improves cognitive impairment and psychiatric symptoms related with SAPAP3 in mouse models of Alzheimer's disease.

Fangtai Yi, Jianfeng Ma, Ruiyue Zhao, Qiuyu Xie, Sitong Lu, Kailong Zhang, Zuodong Zhong, Huijuan OuYang, Yuan Qin, Mingheng Xu, Qin Xue, Xinlu Wang, Wei Wei, Yinghua Liu

European journal of pharmacology · 2026

Neuroscienze Psicologia cognitiva

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

AnimalsAlzheimer DiseaseDisease Models, AnimalMiceZonisamideCognitive DysfunctionMaleHumansAmyloid beta-PeptidesBehavior, AnimalNerve Tissue ProteinsMice, TransgenicAmyloid Precursor Protein Secretases5xFAD miceAlzheimer's diseaseAβSAPAP3Tau

Come citare questo studio

Fangtai Yi, Jianfeng Ma, Ruiyue Zhao, Qiuyu Xie, Sitong Lu, Kailong Zhang, Zuodong Zhong, Huijuan OuYang, Yuan Qin, Mingheng Xu, Qin Xue, Xinlu Wang, Wei Wei, Yinghua Liu. (2026). Zonisamide improves cognitive impairment and psychiatric symptoms related with SAPAP3 in mouse models of Alzheimer's disease.. European journal of pharmacology. DOI: 10.1016/j.ejphar.2026.179279

Consulta la pubblicazione originale ↗